Optibrium, Imperial College and DNDi to collaborate on drug development
The collaboration will provide MSc students with industry-relevant learning tools and pharma with a new pipeline of candidate compounds.
List view / Grid view
The collaboration will provide MSc students with industry-relevant learning tools and pharma with a new pipeline of candidate compounds.
Investigators at Dartmouth's Geisel School of Medicine announced that two new studies of DAR-901, their investigational vaccine against tuberculosis (TB), have moved it to the forefront of new vaccines in development for global control of this deadly infectious disease.
Kymab Group Limited, a leading human monoclonal antibody biopharmaceutical group, announces the appointment of Dr Sonia Quaratino as its first Chief Medical Officer. Dr Quaratino will manage the clinical development of the Group's expanding therapeutic antibody portfolio.
The unpleasant sensation sparked by the nervous system when confronted with a harmful stimulus can be alleviated by blocking a genetic marker that switches off the activity of the neurons involved.
A test that measures the levels of five chemicals in the breath has shown promising results for the detection of oesophageal and stomach cancers, in a large patient trial.
10 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The technology could enable patients with HIV to be managed more effectively in remote locations and can produce a result in under 30 minutes...
17 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Aims to develop, register and make available a new child-friendly formulation for the more than 25 million children suffering from schistosomiasis...
29 September 2016 | By Niamh Louise Marriott, Digital Content Producer
The University of Manchester, Imperial College London, the University of Leeds, and University of Glasgow have all been included in the research grant...
8 September 2016 | By Niamh Louise Marriott, Digital Content Producer
Through a process involving vitamin A, researchers from Imperial College London observed that it was possible to switch off pancreatic stellate cells...
18 August 2016 | By Niamh Louise Marriott, Digital Content Producer
Researchers at Imperial College have studied how the psychedelic substance LSD works in the brain and the effect on speech and language, discovering that...
24 June 2016 | By Victoria White, Digital Content Producer
Scientists have identified antibodies that can efficiently neutralise both the dengue virus and the Zika virus...
13 April 2016 | By Victoria White, Digital Content Producer
The effects of LSD on the human brain have been visualised for the first time and may lead to new treatments for psychiatric disorders...
23 February 2016 | By Victoria White
Given the key role of epigenetics in all tumour types, Desktop Genetics' research has wide potential applications across all histological types of cancer...
25 January 2016 | By Victoria White
The Apollo Therapeutics Fund will support the translation of ground-breaking academic science into innovative new medicines for a broad range of diseases...
15 December 2015 | By Victoria White
The new facility will support science- and technology-based companies striving to build businesses that originated with research from universities and increase their impact...